Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfo.2019.11.043DOI Listing

Publication Analysis

Top Keywords

accidental intralenticular
4
intralenticular injections
4
injections intravitreal
4
intravitreal dexamethasone
4
dexamethasone implant
4
implant cataract
4
cataract formation
4
formation progresses
4
progresses successful
4
successful surgical
4

Similar Publications

A rare intraocular foreign body resulting from a workplace accident.

Arch Soc Esp Oftalmol (Engl Ed)

June 2024

Institut Català de Retina, Barcelona, Spain.

A 54-year-old man presented to the ophthalmic emergency department of our center with eye pain and blurred vision in his right eye following a workplace accident. Examination revealed a penetrating corneal injury with the presence of an intraocular foreign body (IOFB) involving the corneoscleral limbus, perforating the cornea, iris, anterior lens capsule, and lens. Immediate surgical intervention was carried out with the extraction of the IOFB, identified as an 8mm mussel shell fragment, and the removal of the resulting traumatic cataract.

View Article and Find Full Text PDF

Introduction: Intravitreal dexamethasone (DEX) implant is indicated for the treatment of macular oedema due to diabetic retinopathy, retinal vein occlusion and uveitis. The most common complications are cataract and elevated intraocular pressure (IOP). Accidental injection of DEX implant into the lens is a rare complication and only few papers presented it.

View Article and Find Full Text PDF

Intralenticular Ozurdex injection in an eye with thicker lens and the therapeutic effect maintained for 15 months.

Heliyon

December 2022

Department of Ophthalmology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Introduction: To report a case of accidental intralenticular Ozurdex injection in an eye with thicker lens. During the follow-up period of 15 months, the therapeutic effect of intralenticular Ozurdex was maintained.

Case Description: Ozurdex was accidently injected into the lens of an eye with uveitis, and the lens thickness was measured to be 5.

View Article and Find Full Text PDF

To report the therapeutic efficacy and results of an accidentally injected intralenticular sustained-release dexamethasone implant (Ozurdex) in a patient with macular edema secondary to diabetic macular edema. Dexamethasone intravitreal implant is an approved formulation in the management of macular edema. The most common adversarial effects are an elevation of intraocular pressure (IOP) and cataract, but the unintentional injection of the dexamethasone implant into the lens is a particularly rare event.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!